Jones Financial Companies’s ImmunityBio IBRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.51K | Sell |
1,300
-17,086
| -93% | -$46.1K | ﹤0.01% | 3263 |
|
|
2025
Q1 | $57.7K | Buy |
18,386
+12,966
| +239% | +$40.7K | ﹤0.01% | 1998 |
|
|
2024
Q4 | $13.9K | Buy |
5,420
+2,000
| +58% | +$5.12K | ﹤0.01% | 2395 |
|
|
2024
Q3 | $13.4K | Buy |
3,420
+300
| +10% | +$1.18K | ﹤0.01% | 2105 |
|
|
2024
Q2 | $19.7K | Buy |
3,120
+120
| +4% | +$758 | ﹤0.01% | 1540 |
|
|
2024
Q1 | $16.1K | Buy |
+3,000
| New | +$16.1K | ﹤0.01% | 949 |
|